Marynak Kristy L, Cohen Joanna E, Thrul Johannes, Kennedy Ryan D, Limaye Rupali, Moran Meghan B
Office on Smoking and Health, Centers for Disease Control and Prevention, Atlanta, GA.
Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.
Nicotine Tob Res. 2025 May 22;27(6):1006-1015. doi: 10.1093/ntr/ntae298.
Since 2016, the US Food and Drug Administration (FDA) has required e-cigarette packaging and advertising to bear the warning: "WARNING: THIS PRODUCT CONTAINS NICOTINE. NICOTINE IS AN ADDICTIVE CHEMICAL." Nicotine has numerous adverse consequences besides addiction, including increased anxiety and depression symptoms that arise from nicotine withdrawal. We tested the effects of exposure to text-only e-cigarette package labels about the psychological consequences of nicotine withdrawal.
We randomized 1919 US young adults aged 18-24 years to view one of four warning label conditions: a no-message control, the current FDA warning, a message that "nicotine addiction can worsen depression and anxiety symptoms," and a message that "nicotine addiction is a source of stress." We explored associations between condition and intentions to use or quit e-cigarettes and perceived message effectiveness.
Label condition was not associated with intentions to use or quit e-cigarettes. Intentions were equivalent among those who viewed the FDA label and those who viewed the no-message control. Compared with the FDA label, the depression/anxiety label and the stress label produced greater agreement among participants that the message "makes me concerned about nicotine addiction" after adjustment for sociodemographic characteristics; those who viewed the depression/anxiety label had greater agreement that the message "discourages me from wanting to use nicotine."
While brief exposure to the warnings tested may not impact young adults' intentions to use or quit vaping, messages about stress, depression, and anxiety arising from nicotine addiction had higher perceived effectiveness among young adults than the FDA's current message about addictiveness.
Findings from this randomized controlled experiment among US young adults suggest that warnings about the mental health consequences of nicotine addiction might be one type of message to consider including in a suite of required e-cigarette warnings and as part of a comprehensive effort to educate the public about the risks of commercial tobacco products.
自2016年以来,美国食品药品监督管理局(FDA)要求电子烟包装和广告须带有以下警示语:“警告:本产品含有尼古丁。尼古丁是一种成瘾性化学物质。” 除成瘾外,尼古丁还有许多不良后果,包括尼古丁戒断引起的焦虑和抑郁症状加重。我们测试了仅接触关于尼古丁戒断心理后果的电子烟包装文字标签所产生的影响。
我们将1919名年龄在18至24岁之间的美国年轻人随机分组,让他们观看以下四种警示标签中的一种:无信息对照组、FDA现行警示语、“尼古丁成瘾会加重抑郁和焦虑症状”的信息以及“尼古丁成瘾是压力源”的信息。我们探究了分组情况与使用或戒烟意图以及感知到的信息有效性之间的关联。
标签分组情况与使用或戒烟意图无关。观看FDA标签的人和观看无信息对照组的人在意图方面相当。与FDA标签相比,在调整社会人口统计学特征后,抑郁/焦虑标签和压力标签在参与者中产生了更大的共识,即该信息 “让我担心尼古丁成瘾”;观看抑郁/焦虑标签的人更认同该信息 “使我不想使用尼古丁”。
虽然短暂接触所测试的警示语可能不会影响年轻人使用或戒烟的意图,但关于尼古丁成瘾导致的压力、抑郁和焦虑的信息在年轻人中比FDA目前关于成瘾性的信息具有更高的感知有效性。
在美国年轻人中进行的这项随机对照实验结果表明,关于尼古丁成瘾对心理健康影响的警示语可能是一类需要考虑纳入一系列必要的电子烟警示语中的信息,并且是向公众宣传商业烟草产品风险的全面努力的一部分。